FREE ACCESS FOR HCPs
Brought to you by MD Education
HCP Free Registration
Healthcare professionals click below to register free of charge
HCPs register here
Prof. Dr. Srdan Verstovsek
Dr. Srdan Verstovsek is a Medical Oncologist and Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center, Houston, USA with research focused on understanding the biology of and developing new therapies for Myeloproliferative Neoplasms (MPNs).
Dr. Rami Komrokji
Rami S. Komrokji, MD, is a clinical investigator at H. Lee Moffitt Cancer Center. His research focus is on phase I and II clinical trials in Myelodysplastic syndromes (MDS) and acute myeloid leukemia. Currently, he is the lead clinical investigator for the MDS Program at the Cancer Center and has conducted several translational clinical trials working with basic scientists.
As well as developing the MDS database, which is one of the largest in the world, he also serves as the Moffitt Cancer Center PI for the MDS Clinical Consortium, which is an agreement between 6 largest MDS Program in the country for conducting clinical trials in MDS.
Dear Colleagues and Friends,
On behalf of the co-chairs, Prof. Srdan Verstovsek and Dr. Rami Komrokji, MD Education are proud to announce the 2020 MPN-MDS US Focus meeting will be held virtually on November 5-7 2020.
Featuring 30 MPN and MDS clinical experts from across the United States, the theme of the meeting, International Knowledge & Clinical Practice in 2020, reflects the collaboration to advance the research and treatment of patients with MPN & MDS globally.
The 3 day meeting will include presentations, round-table discussions, Q&A sessions with the presenters and poster sessions, all held virtually. This is a unique opportunity to garner knowledge, skills, and experience from leading clinicians to assess best practices and state-of-the-art treatments in MDS and MPN for your patients.
